Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intraindividual Comparison Between [18F] PSMA-1007 PET/CT and Multiparametric MRI for Radiotherapy Planning in Primary Prostate Cancer Patients.
Marinescu IM, Spohn SKB, Kiefer S, Bronsert P, Ceci L, Holzschuh J, Sigle A, Jilg CA, Rühle A, Sprave T, Nicolay NH, Winzer R, Rehm J, Kotzerke J, Hölscher T, Grosu AL, Ruf J, Benndorf M, Zamboglou C. Marinescu IM, et al. Among authors: holscher t. Front Oncol. 2022 Jul 14;12:880042. doi: 10.3389/fonc.2022.880042. eCollection 2022. Front Oncol. 2022. PMID: 35912219 Free PMC article.
Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
Gillham C, Zips D, Pönisch F, Evers C, Enghardt W, Abolmaali N, Zöphel K, Appold S, Hölscher T, Steinbach J, Kotzerke J, Herrmann T, Baumann M. Gillham C, et al. Among authors: holscher t. Radiother Oncol. 2008 Sep;88(3):335-41. doi: 10.1016/j.radonc.2008.05.004. Epub 2008 May 29. Radiother Oncol. 2008. PMID: 18514339
PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives.
Zschaeck S, Lohaus F, Beck M, Habl G, Kroeze S, Zamboglou C, Koerber SA, Debus J, Hölscher T, Wust P, Ganswindt U, Baur ADJ, Zöphel K, Cihoric N, Guckenberger M, Combs SE, Grosu AL, Ghadjar P, Belka C. Zschaeck S, et al. Among authors: holscher t. Radiat Oncol. 2018 May 11;13(1):90. doi: 10.1186/s13014-018-1047-5. Radiat Oncol. 2018. PMID: 29751842 Free PMC article. Review.
Dual-time-point 64 Cu-PSMA-617-PET/CT in patients suffering from prostate cancer.
Hoberück S, Wunderlich G, Michler E, Hölscher T, Walther M, Seppelt D, Platzek I, Zöphel K, Kotzerke J. Hoberück S, et al. Among authors: holscher t. J Labelled Comp Radiopharm. 2019 Jun 30;62(8):523-532. doi: 10.1002/jlcr.3745. Epub 2019 Jun 17. J Labelled Comp Radiopharm. 2019. PMID: 31042811
68Ga-RM2 PET in PSMA- positive and -negative prostate cancer patients.
Hoberück S, Michler E, Wunderlich G, Löck S, Hölscher T, Froehner M, Braune A, Ivan P, Seppelt D, Zöphel K, Kotzerke J. Hoberück S, et al. Among authors: holscher t. Nuklearmedizin. 2019 Sep;58(5):352-362. doi: 10.1055/a-0990-8898. Epub 2019 Aug 23. Nuklearmedizin. 2019. PMID: 31443113 English.
Radiotherapy in nodal oligorecurrent prostate cancer.
Pinkawa M, Aebersold DM, Böhmer D, Flentje M, Ghadjar P, Schmidt-Hegemann NS, Höcht S, Hölscher T, Müller AC, Niehoff P, Sedlmayer F, Wolf F, Zamboglou C, Zips D, Wiegel T. Pinkawa M, et al. Among authors: holscher t. Strahlenther Onkol. 2021 Jul;197(7):575-580. doi: 10.1007/s00066-021-01778-1. Epub 2021 Apr 29. Strahlenther Onkol. 2021. PMID: 33914101 Free PMC article. Review.
125 results